Related references
Note: Only part of the references are listed.Tacrolimus is an effective treatment for lupus nephritis in pregnancy
P. Webster et al.
LUPUS (2014)
Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
Helio Tedesco Silva et al.
TRANSPLANTATION (2014)
Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus
C. C. Mok et al.
ARTHRITIS AND RHEUMATISM (2013)
Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus
C. C. Mok et al.
ARTHRITIS AND RHEUMATISM (2013)
Lupus nephritis: a 15-year multi-centre experience in the UK
M. Hui et al.
LUPUS (2013)
Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study
C. C. Mok et al.
LUPUS (2013)
Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum
Mary F. Hebert et al.
TRANSPLANTATION (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial
W. Chen et al.
LUPUS (2012)
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
Xiao Li et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
Wei Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials
Y. H. Lee et al.
LUPUS (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help
S. Heidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
Luit Penninga et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review
Kam Hon Yoon
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Jai Radhakrishnan et al.
KIDNEY INTERNATIONAL (2010)
Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis
T. Lee et al.
LUPUS (2010)
The Relationship Between Renal Activity and Quality of Life in Systemic Lupus Erythematosus
Simone Appenzeller et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Clinical Assessment of Tacrolimus Therapy in Lupus Nephritis: One-Year Follow-Up Study in a Single Center
Yukari Asamiya et al.
NEPHRON CLINICAL PRACTICE (2009)
The safety of mycophenolate mofetil in pregnancy
Cecilia N. Pisoni et al.
EXPERT OPINION ON DRUG SAFETY (2008)
Successful treatment of class V+IV lupus nephritis with multitarget therapy
Hao Bao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation:: three-year observational results
Bernhard K. Kraemer et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
C. -C. Szeto et al.
RHEUMATOLOGY (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Severe lupus nephritis: Racial differences in presentation and outcome
Stephen M. Korbet et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide
CC Mok et al.
AMERICAN JOURNAL OF MEDICINE (2006)
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
MH Liang et al.
ARTHRITIS AND RHEUMATISM (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis
LM Ong et al.
NEPHROLOGY (2005)
Incidence and risk factors of thromboembolism in systemic lupus erythematosus - A comparison of three ethnic groups
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2005)
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study
CC Mok et al.
KIDNEY INTERNATIONAL (2005)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
JP Buyon et al.
ANNALS OF INTERNAL MEDICINE (2005)
Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus
CC Mok et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
HM Bastian et al.
LUPUS (2002)
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
GG Illei et al.
ANNALS OF INTERNAL MEDICINE (2001)
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature
D Hallegua et al.
LUPUS (2000)
Share Paper
